3. INVESTMENTS
For the years ended December 31, 2017 and 2016, the Company had the following investments:
|
|
Accumulated | ||||||||
|
December 31, 2017 |
Cost | unrealized loss | Fair value | ||||||
|
Fair value through profit or loss |
|||||||||
|
Marketable securities |
$ | 2,396,251 | $ | (1,256,804 | ) | $ | 1,139,447 | ||
|
Total Fair value through profit or loss |
2,396,251 | (1,256,804 | ) | 1,139,447 | |||||
|
Available-for-sale |
|||||||||
|
Marketable securities |
2,287,141 | (87,942 | ) | 2,199,199 | |||||
|
Total investments |
$ | 4,683,392 | $ | (1,344,746 | ) | $ | 3,338,646 |
|
|
Accumulated | ||||||||
|
December 31, 2016 |
Cost | unrealized loss | Fair value | ||||||
|
Fair value through profit or loss |
|||||||||
|
Marketable securities |
$ | 1,641,751 | $ | (1,378,995 | ) | $ | 262,756 | ||
|
Total Fair value through profit or loss |
1,641,751 | (1,378,995 | ) | 262,756 | |||||
|
Available-for-sale |
|||||||||
|
Marketable securities |
910,473 | (697,675 | ) | 212,798 | |||||
|
Total investments |
$ | 2,552,224 | $ | (2,076,670 | ) | $ | 475,554 |
During the year ended December 31, 2017, the Company recorded a loss of $Nil (2016 - $697,675) related to the permanent impairment of certain available-for-sale marketable securities. The Company had sustained significant unrealized losses for which there was no expectation of reversal in the forseable future.